Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,863 |
Reported balance
After 2026-03-18 transaction · row 1
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 46,863 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.61 | $46.93 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,387 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 20, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.52 | $45.76 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,374 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 17, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.48 | $45.24 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,361 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 16, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.49 | $45.37 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,348 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 15, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.37 | $43.81 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,335 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 14, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.35 | $43.55 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,322 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 13, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.54 | $46.02 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,309 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 10, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.59 | $46.67 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,296 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 09, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.56 | $46.28 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,283 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 08, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.63 | $47.19 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,270 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 07, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.19 | $41.47 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,257 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 06, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.14 | $40.82 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,244 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 03, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.25 | $42.25 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,231 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 02, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.28 | $42.64 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,218 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 01, 2025 Filed Nov 3, 2025 12:58 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.31 | $43.03 |
DisclosureSEC source: 0001490829-25-000005 · wk-form4_1762174694.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,205 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.12 | $40.56 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,192 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 29, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.14 | $40.82 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,179 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 26, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.05 | $36.60 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,166 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 25, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.10 | $37.20 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,154 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 24, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.10 | $37.20 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,142 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 23, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.21 | $38.52 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,130 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 22, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.29 | $39.48 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,118 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 19, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.34 | $40.08 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,106 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 18, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.31 | $39.72 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,094 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 17, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.38 | $40.56 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,082 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 16, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.50 | $42.00 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,070 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 15, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.50 | $42.00 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,058 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 12, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.54 | $42.48 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,046 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 11, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.41 | $40.92 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,034 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 10, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.39 | $40.68 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 7 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,022 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 09, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.43 | $41.16 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 6 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,010 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 08, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.41 | $40.92 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 5 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,998 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 05, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.60 | $43.20 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 4 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,986 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 04, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.60 | $43.20 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 3 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,974 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 03, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.58 | $42.96 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 2 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,962 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 02, 2025 Filed Oct 3, 2025 20:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.54 | $42.48 |
DisclosureSEC source: 0001087294-25-000008 · wk-form4_1759521732.xml · nonDerivative · entry 1 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,950 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 29, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.45 | $44.85 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 21 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,938 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 28, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.47 | $45.11 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 20 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,925 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 27, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.44 | $44.72 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 19 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,912 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 26, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.39 | $44.07 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 18 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,899 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 25, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.32 | $43.16 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 17 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,886 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 22, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.31 | $43.03 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 16 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,873 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 21, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.25 | $42.25 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 15 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,860 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 20, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 2 | $3.15 | $6.30 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 14 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,847 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 19, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.23 | $41.99 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 13 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,845 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 18, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.11 | $40.43 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 12 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,832 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 15, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.02 | $39.26 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 11 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,819 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 14, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.84 | $36.92 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 10 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,806 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 13, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.94 | $38.22 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 9 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,793 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 12, 2025 Filed Sep 12, 2025 12:35 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.91 | $37.83 |
DisclosureSEC source: 0001628280-25-041987 · wk-form4_1757680522.xml · nonDerivative · entry 8 Jones James · CIK 0001490829 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,780 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.